{"id":"antifibrinolytic-treatment","safety":{"commonSideEffects":[{"rate":"null","effect":"Hypersensitivity reactions"},{"rate":"null","effect":"Thrombosis"}]},"_chembl":{"chemblId":"CHEMBL7257","moleculeType":"Small molecule","molecularWeight":"218.30"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"They work by blocking the conversion of plasminogen to plasmin, which is involved in the breakdown of fibrin clots.","oneSentence":"Antifibrinolytic agents inhibit plasminogen activators and plasmin.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:10:34.238Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of bleeding in patients with hemophilia A or B"},{"name":"Prevention of excessive bleeding during and following surgery"}]},"trialDetails":[{"nctId":"NCT07410130","phase":"","title":"Clinical Spectrum and Management of Von Willebrand Disease Among Children in Assiut Governorate","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-03","conditions":"Von Willebrand Disease (VWD), Inherited Bleeding Disorders in Children, Pediatric Hemostatic Disorders","enrollment":25},{"nctId":"NCT03136445","phase":"PHASE3","title":"TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia","status":"COMPLETED","sponsor":"NHS Blood and Transplant","startDate":"2015-06","conditions":"Hematologic Neoplasms, Hemorrhage, Hematopoietic Stem Cell Transplantation","enrollment":616},{"nctId":"NCT03424460","phase":"NA","title":"Venous Thromboembolism in Myotonic Dystrophy Type 1","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-06-11","conditions":"Myotonic Dystrophy 1","enrollment":130},{"nctId":"NCT04562610","phase":"PHASE2, PHASE3","title":"Enhanced Recovery After Surgery in Orthopaedic Spine Surgery","status":"COMPLETED","sponsor":"University of California, Davis","startDate":"2020-11-18","conditions":"Lumbar Surgery","enrollment":33},{"nctId":"NCT06425614","phase":"NA","title":"COmbined pLaTelet and eRythrocyte AutotransfusioN During Cardiac surgEry (COLTRANE) Trial","status":"RECRUITING","sponsor":"University Hospital, Bordeaux","startDate":"2024-07-15","conditions":"On-pump Cardiac Surgery, High Risk for Bleeding, Autotransfusion","enrollment":570},{"nctId":"NCT05419505","phase":"PHASE2","title":"Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the Buttocks","status":"COMPLETED","sponsor":"Endo Pharmaceuticals","startDate":"2022-06-15","conditions":"Edematous Fibrosclerotic Panniculopathy, Cellulite","enrollment":91},{"nctId":"NCT04272606","phase":"PHASE2","title":"TXA in Spinal Fusion","status":"COMPLETED","sponsor":"Catherine R. Olinger","startDate":"2020-08-01","conditions":"Degenerative Disc Disease","enrollment":123},{"nctId":"NCT06710327","phase":"PHASE4","title":"Effect of Tranexamic Acid on Intraoperative Blood Loss in Patients Undergoing Aquablation","status":"NOT_YET_RECRUITING","sponsor":"Kaiser Permanente","startDate":"2025-01","conditions":"Benign Prostatic Hyperplasia","enrollment":56},{"nctId":"NCT04760977","phase":"","title":"Prehospital Management of Hypotensive Trauma in HEMS","status":"RECRUITING","sponsor":"Azienda Usl di Bologna","startDate":"2021-05-01","conditions":"Hypotension and Shock, Wounds and Injuries, Emergencies","enrollment":500},{"nctId":"NCT03469947","phase":"PHASE3","title":"California Prehospital and In Hospital Antifibrinolytic Therapy Via TXA","status":"COMPLETED","sponsor":"Arrowhead Regional Medical Center","startDate":"2015-03","conditions":"Hemorrhagic Shock, Trauma Injury","enrollment":200},{"nctId":"NCT04814433","phase":"PHASE4","title":"Evaluating Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled With Modulated Coagulation","status":"TERMINATED","sponsor":"NYU Langone Health","startDate":"2021-03-24","conditions":"Opioid Pain Medication","enrollment":46},{"nctId":"NCT06149091","phase":"EARLY_PHASE1","title":"Control of Iatrogenic Endobronchial Bleeding by Tranexamic Acid, Adrenalin and Hemagglutinase","status":"UNKNOWN","sponsor":"China-Japan Friendship Hospital","startDate":"2023-12-01","conditions":"Iatrogenic Endobronchial Bleeding","enrollment":300},{"nctId":"NCT03385928","phase":"PHASE2","title":"STOP-MSU: Stopping Haemorrhage With Tranexamic Acid for Hyperacute Onset Presentation Including Mobile Stroke Units","status":"COMPLETED","sponsor":"Neuroscience Trials Australia","startDate":"2018-03-19","conditions":"Intracerebral Haemorrhage","enrollment":201},{"nctId":"NCT05708690","phase":"PHASE4","title":"Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2022-10-01","conditions":"Coronary Artery Disease, Valvular Heart Disease, Surgical Blood Loss","enrollment":132},{"nctId":"NCT04373603","phase":"PHASE4","title":"Use of Tranexamic Acid in Facial Fillers","status":"WITHDRAWN","sponsor":"University of Wisconsin, Madison","startDate":"2022-07","conditions":"Injection Site Bruising","enrollment":""},{"nctId":"NCT02074436","phase":"PHASE2","title":"PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid)","status":"TERMINATED","sponsor":"Emory University","startDate":"2014-05-23","conditions":"Hematological Malignancies, Thrombocytopenia","enrollment":29},{"nctId":"NCT04804345","phase":"","title":"AProtinin Versus Tranexamic Acid in Cardiac Surgery Patients With High-risk for Excessive Bleeding","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2021-03-31","conditions":"Cardiac Surgery, Cardiopulmonary Bypass, High Risk Bleeding","enrollment":693},{"nctId":"NCT03317795","phase":"PHASE4","title":"Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids","status":"COMPLETED","sponsor":"Shannon K. Laughlin-Tommaso","startDate":"2017-11-14","conditions":"Heavy Menstrual Bleeding, Menorrhagia, Uterine Fibroids","enrollment":18},{"nctId":"NCT04555343","phase":"PHASE1, PHASE2","title":"Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention","status":"COMPLETED","sponsor":"Fraser Health","startDate":"2021-03-01","conditions":"Urologic Diseases, Prostate Cancer, Bladder Cancer","enrollment":14},{"nctId":"NCT04753151","phase":"NA","title":"The Effects of Tranexamic Acid or Placebo on Perioperative Bleeding in Adults Undergoing Liver Transplantation.","status":"UNKNOWN","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2021-08-11","conditions":"Hemorrhage","enrollment":140},{"nctId":"NCT03347591","phase":"","title":"Rare Bleeding Disorders in the Netherlands","status":"UNKNOWN","sponsor":"Radboud University Medical Center","startDate":"2017-11-07","conditions":"Rare Bleeding Disorders","enrollment":300},{"nctId":"NCT02684812","phase":"PHASE2, PHASE3","title":"Ultra-early Tranexamic Acid After Subarachnoid Hemorrhage.","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2012-07-16","conditions":"Subarachnoid Hemorrhage","enrollment":955},{"nctId":"NCT01658124","phase":"PHASE3","title":"Haemorrhage Alleviation With Tranexamic Acid- Intestinal System","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2013-07","conditions":"Gastrointestinal Bleeding","enrollment":12009},{"nctId":"NCT01702636","phase":"PHASE2","title":"STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial","status":"COMPLETED","sponsor":"Neuroscience Trials Australia","startDate":"2012-12","conditions":"Intracerebral Haemorrhage, Stroke","enrollment":100},{"nctId":"NCT01402882","phase":"PHASE3","title":"Clinical Randomisation of an Antifibrinolytic in Significant Head Injury","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2012-07","conditions":"Traumatic Brain Injury","enrollment":12737},{"nctId":"NCT03054662","phase":"NA","title":"Non Substitutive Strategies to Improve Haemophilia Care in Developing Countries. Experience in Ivory Coast.","status":"COMPLETED","sponsor":"Cliniques universitaires Saint-Luc- Université Catholique de Louvain","startDate":"2017-01-16","conditions":"Haemophilia, Developing Countries","enrollment":142},{"nctId":"NCT03101124","phase":"PHASE2","title":"Serum Concentration of Tranexamic Acid After Topical Administration in Massive Weight Loss Skin Reducing Surgery","status":"COMPLETED","sponsor":"St. Olavs Hospital","startDate":"2017-05-01","conditions":"Surgical Wound, Bleeding","enrollment":36},{"nctId":"NCT01089140","phase":"PHASE2","title":"Non-Idiopathic Scoliosis Treated With Tranexamic Acid","status":"TERMINATED","sponsor":"The Hospital for Sick Children","startDate":"2014-11","conditions":"Non-idiopathic Scoliosis","enrollment":2},{"nctId":"NCT03023189","phase":"PHASE4","title":"Efficacity and Safety of Tranexamic Acid in Cirrhotic Patients Presenting With Acute Upper Gastrointestinal Bleeding","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-04-03","conditions":"Upper Digestive Bleeding, Cirrhosis","enrollment":500},{"nctId":"NCT00872469","phase":"PHASE3","title":"World Maternal Antifibrinolytic Trial","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2009-05","conditions":"Postpartum Haemorrhage","enrollment":20060},{"nctId":"NCT02043132","phase":"PHASE2, PHASE3","title":"Tranexamic Acid in Reverse Total Shoulder Arthroplasty","status":"COMPLETED","sponsor":"Corewell Health East","startDate":"2013-09","conditions":"Shoulder Joint Disease, Complications; Arthroplasty, Intraoperative Complications","enrollment":116},{"nctId":"NCT01873768","phase":"PHASE4","title":"Clinical Efficacy of Tranexamic Acid and ε-Aminocaproic Acid in Reducing Blood Loss Following Total Knee Replacement","status":"COMPLETED","sponsor":"Miller Orthopedic Specialists","startDate":"2014-01","conditions":"Osteoarthritis","enrollment":194},{"nctId":"NCT02323373","phase":"PHASE2","title":"Topical Versus Intravenous Tranexamic Acid in Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Irmandade da Santa Casa de Misericordia de Sao Paulo","startDate":"2014-06","conditions":"Arthrosis","enrollment":90},{"nctId":"NCT01476423","phase":"","title":"Observational Registry of the Treatment of Glanzmann's Thrombasthenia","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2004-01","conditions":"Congenital Bleeding Disorder, Glanzmann's Disease","enrollment":218},{"nctId":"NCT01713101","phase":"PHASE3","title":"Tranexamic Acid for Upper Gastrointestinal Bleeding","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2012-10","conditions":"Acute Upper Gastrointestinal Hemorrhage","enrollment":414},{"nctId":"NCT01519245","phase":"PHASE3","title":"Topical Application of Tranexamic Acid to Reduce Post-operative Bleeding in Coronary Artery Bypass Surgery","status":"COMPLETED","sponsor":"University of Saskatchewan","startDate":"2011-12","conditions":"Coronary Artery Disease","enrollment":44},{"nctId":"NCT01085487","phase":"","title":"MiCo - Mirena or Conventional Medical Treatment for Menorrhagia","status":"COMPLETED","sponsor":"Bayer","startDate":"2009-04","conditions":"Idiopathic Menorrhagia","enrollment":1211},{"nctId":"NCT01060163","phase":"NA","title":"Tranexamic Acid in Clopidogrel Exposure to Decrease Hemorrhage and Transfusion","status":"COMPLETED","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2010-01","conditions":"Coronary Artery Disease","enrollment":552},{"nctId":"NCT00375258","phase":"PHASE3","title":"Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2005-05","conditions":"Hemorrhage","enrollment":20211},{"nctId":"NCT01216150","phase":"","title":"Impact of Combination of Clopidogrel With Aspirin on Postoperative Bleeding in Coronary Surgical Patients","status":"COMPLETED","sponsor":"Groupe Hospitalier Pitie-Salpetriere","startDate":"2009-12","conditions":"Coronary Surgery, Hemorrhage","enrollment":150},{"nctId":"NCT00994994","phase":"NA","title":"Tranexamic Acid in Pediatric Cardiac Surgery","status":"COMPLETED","sponsor":"Okayama University","startDate":"2006-01","conditions":"Blood Loss, Congenital Heart Disease","enrollment":160},{"nctId":"NCT00147862","phase":"PHASE3","title":"Does Tranexamic Acid Administration Reduce Blood Loss During Head and Neck Surgery?","status":"COMPLETED","sponsor":"Tata Memorial Hospital","startDate":"2005-05","conditions":"Head and Neck Neoplasms","enrollment":240}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":124,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Antifibrinolytic treatment","genericName":"Antifibrinolytic treatment","companyName":"Bayer","companyId":"bayer","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Antifibrinolytic agents inhibit plasminogen activators and plasmin. Used for Treatment of bleeding in patients with hemophilia A or B, Prevention of excessive bleeding during and following surgery.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}